Salix Central

Artrya Limited · K243038 · 2025-03-27

Salix Central is an AI-enabled medical device from Artrya Limited, listed by FDA (510(k), K243038) with a decision date of 2025-03-27. Review panel: Radiology.

FDA submission numberK243038
Pathway510(k)
CompanyArtrya Limited
Review panel (specialty)Radiology
FDA decision date2025-03-27
DecisionSubstantially Equivalent
Product codeQIH
ClassificationAutomated Radiological Image Processing Software
Device class2
Regulation number892.2050
Review time (calendar days)181
Applicant countryAU

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.